首页> 外国专利> Crystal form a and B - (2R) - 3 - methyl - 2 - tetrahydrofuryl) tioxantina inhibitor; Myeloperoxidase; processes for their Preparation; Pharmaceutical formulation that comprises; and use in the treatment ofNeuroinflammatory disorders, and atherosclerotic cardio cerebrovascular disorders, Heart Failure, bronchitis.

Crystal form a and B - (2R) - 3 - methyl - 2 - tetrahydrofuryl) tioxantina inhibitor; Myeloperoxidase; processes for their Preparation; Pharmaceutical formulation that comprises; and use in the treatment ofNeuroinflammatory disorders, and atherosclerotic cardio cerebrovascular disorders, Heart Failure, bronchitis.

机译：晶型a和B-（2R）-3-甲基-2-四氢呋喃基）噻吨黄酮抑制剂;髓过氧化物酶;制备过程;药物制剂，其包含;并用于治疗神经炎性疾病和动脉粥样硬化性心脑血管疾病，心力衰竭，支气管炎。

页面导航

摘要
著录项
相似文献

摘要

Crystal form a and B - (2R) - 3 - methyl - 2 - tetrahydrofuryl) tioxantina; Preparation Process; Pharmaceutical formulation that comprises; and use in the treatment of diseases, such as COPD,Bronchitis, Heart Failure, and atherosclerotic cardio cerebrovascular disorders, among others.

机译：晶型a和B-（2R）-3-甲基-2-四氢呋喃基）噻吨黄素;制备过程;药物制剂，其包含;并用于治疗疾病，例如COPD，支气管炎，心力衰竭和动脉粥样硬化性心脑血管疾病等。

著录项

公开/公告号CL2008001766A1

专利类型
公开/公告日2008-12-19

原文格式PDF
申请/专利权人 ASTRAZENECA AB;
展开▼

申请/专利号CL20080001766
发明设计人 ASLUND BENGT;EHRL ROBERT.;
展开▼

申请日2008-06-13
分类号A61K31/522;A61P11/00;A61P9/04;A61P9/10;C07D473/02;
国家 CL
入库时间 2022-08-21 19:28:21

相似文献

专利
外文文献